Transformation of B cell lymphoma to histiocytic sarcoma: Somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation

被引：24

作者：

Bassarova A. ^{[1
]}

Trøen G. ^{[1
]}

Fosså A. ^{[2
]}

Ikonomou I.M. ^{[1
]}

Beiske K. ^{[1
]}

Nesland J.M. ^{[1
]}

Delabie J. ^{[1
]}

机构：

[1] Department of Pathology, Oslo University Hospital-The Norwegian Radium Hospital, University of Oslo

[2] Department of Oncology, Oslo University Hospital-The Norwegian Radium Hospital, University of Oslo, Oslo

来源：

Journal of Hematopathology | 2009年 / 2卷 / 3期

关键词：

B-cell; Histiocytic; Lymphoma; PAX-5; Sarcoma; Transdifferentiation;

D O I：

10.1007/s12308-009-0031-2

中图分类号：

学科分类号：

摘要：

Transdifferentiation of B cell lymphoma of germinal center cell origin to histiocytic sarcoma has recently been described but is a rare occurrence. The cause for loss of B cell differentiation in these lymphomas is unknown. We investigated whether somatic hypermutation of the PAX-5 gene, a transcription factor that is important for maintaining B cell identity and is frequently mutated in B cell lymphomas of germinal center cell origin, might be a cause for loss of PAX-5 expression and thus B cell phenotype. However, no somatic hypermutation of the PAX-5 gene was detected in the two cases we studied. The molecular basis for transdifferentiation of B cell lymphoma to histiocytic sarcoma remains therefore unresolved. © Springer-Verlag 2009.

引用

页码：135 / 141

页数：6

共 12 条

[1] Jaffe R., Pileri S., Facchetti F., Jones D.M., Jaffe E.S., Histiocytic and dendritic neoplasms World Health Organization Classification of Tumors, Tumours of Haematopoietic and Lymphoid Tissues, (2008)
[2] Pileri S.A., Grogan T.M., Harris N.L., Et al., Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases, Histopathology, 41, pp. 1-29, (2002)
[3] Nichols C.R., Roth B.J., Heerema N., Et al., Hematologic neoplasia associated with primary mediastinal germ-cell tumors, N Engl J Med, 322, pp. 1425-1429, (1990)
[4] Baer M.R., Krantz S.B., Cousar J.B., Et al., Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two cases, Cancer, 57, pp. 2175-2184, (1986)
[5] Wetzler M., Kurzrock R., Goodacre A.M., Et al., Transformation of chronic lymphocytic leukemia to ymphoma of true histiocytic type, Cancer, 76, pp. 609-617, (1995)
[6] Vasef M.A., Zaatari G.S., Chan W.C., Et al., Dendritic cell tumors associated with low-grade B-cell malignancies. Report of three cases, Am J Clin Pathol, 104, pp. 696-701, (1995)
[7] Feldman A.L., Arber D.A., Pittaluga S., Et al., Clonally related follicular evidence for transdifferentiation of the follicular lymphoma clone, Blood, 111, pp. 5433-5439, (2008)
[8] Pasqualucci L., Neumeister P., Goossens T., Et al., Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas, Nature, 412, pp. 341-346, (2001)
[9] Nutt S.L., Heavey B., Rolink A.G., Busslinger M., Commitment to the B-lymphoid lineage depends on the transcription factor Pax5, Nature, 401, pp. 556-562, (1999)
[10] van Dongen J.J., Langerak A.W., Bruggemann M., Et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia, 17, pp. 2257-2317, (2003)

← 1 2 →